PENILE PLASTIC INDURATION (PEYRONIE'S DISEASE)
Authors:
as. MUDr. Pavel Navrátil, CSc.
Authors‘ workplace:
Urologická klinika LF UK a FN Hradec Králové
Published in:
Urol List 2006; 4(1): 57-61
Overview
Penile Plastic Induration (IPP) is a benign disease of unclear etiology. Symptomatic therapy is recommended. Pain is currently treated conservatively, penile deformities can be surgically repaired. Many procedures are described for treatment of erectile dysfunction (ED), penile prosthesis implantation is often the mainstay of therapy.
KEY WORDS:
Penile Plastic Induration, Peyronie´s disease, erectile dysfunction, penis curvature
Sources
1. Akkus E, Breza J, Rehman J et al. Is Colchicin effective in Peyronie´s disease: a Pilot study. Urology 1994; 44: 291-295.
2. Anafarta K, Beduk Y, Uluoglu O et al. The significance of histopatological changes of the normal tunica albuginea in Peyronie´s disease. Int Urol Nephrol 1994; 26: 71-77.
3. Austoni E, Colombo F, Romano AL et al. Soft prosthesis ans relaxing albugineal incision with saphenous grafting for surgical therapy of Peyronie´s disease: a 5 year experience and long term follow-up on 145 operated patients. Eur Urol 2005; 47: 223-9.
4. Brock G, Hsu GL, Nunes L et al. The anatomy of the tunica albuginea in the normal penis and Peyronie´s disease. J Urol 1997; 157: 276-281.
5. Cavallini G. Towards an evidence - based understanding of Peyronie´s disease. Int J STD AIDS 2005; 16: 187-194.
6. Colleta AA, Wakefield LM, Hocvel FV et al. Antisetrogen induce the secretion of stive transforming grow factor beta from human fetal fibroblasts. Br J Cancer 1990; 62: 405-409.
7. Dominiguez-Malagon HR, Alfeiran-Ruiz A, Chavanna-Xicotencalt P. Clinical and cellular efects of colchicine in Fibromatosis. Cancer 1992; 69: 2478-2483.
8. El-Sakka SI, Tayeb KA. Peyronies disease in diabetic patients being screened for erectile dysfunction. J Urol 2005; 174: 1026-1030.
9. Essed E, Schroeder FH. New surgical treatment for Peyronie disease. Urology 1985; 25: 582-587.
10. Hall JS, Bacile G, Bertero EB et al. Extensive corporeal fibrosis after penile iradiation. J Urol 1995; 122: 372-377.
11. Kadioglu A, Oktar T, Kandirali E et al. Incidentally diagnosed Peyronie´s disease in men presenting with erectile dysfunction. Int J Impot Res 2004; 16: 540-543.
12. Kalsi J, Minhas S, Christopher N, Ralph D, The results of plaque incision and venous grafting (Lue procedure) to correctore the penile deformity of Peyronie´s disease. BJU Int 2005; 95: 1029-1033.
13. Kelami A. Peyronie disease and surgical trereatment: a new concept. Urology 1980; 15: 550-561.
14. Kendirci M, Nowfar S, Gur S et al. The relationship between the type of penile abnormality and penile vascular status in patients with peyronies disease. J Urol 2005; 174: 632-635.
15. Khouaja K, Delmas V, Boccon-Gibod L. Leriche technique for the treatment of La Peyronie´s disease. Prog Urol 2004; 14: 586-589.
16. Navratil P, Dimanovski J. Induratio Penis Plastica. In: Kropfl D, Novak R, Tucak A (eds). Rekonstruktive urologische Chirurgie. 1. ed. Lengerich-Berlin-Bremen-Riga-Rom-Viernheim-Wien-Zagreb: Pabst Science Publischers 2002: 495-501.
17. Levine LA, Merricka PF, Lee RC. Intzralesion Verapamil injection for the treatement of Peyronie´s disease. J Urol 1994; 151: 1522-1524.
18. Lindsay MB. The incidence of Peyronie´s disease in Rochester Minnesota 1950 trough 1984. J Urol 1991; 146: 1007-1009.
19. Maloy TR. Advance Pyeronie´s disease treated with the inflatable prosthesis. J Urol 1981; 146: 1007-1009.
20. Mulcahy JJ, Wilson SK. Management of Peyronie's disease with penile prostheses. Int J Impot Res 2002; 14(5): 384-388.
21. Navalon VP, Zaragoza FC, Sanchez BF et al. Correction of penile curvature in ambulatory surgery. Actas Urol Esp 2005; 29: 217-222.
22. Navrátil P, Broïák M. Puls magnetic fields and Peyronie´s disease. Abstract Book EAU Congress. Stockholm 1999: 96.
23. Ralph DJ, Bottazzo GF, Pryor JP. The treatment of Peyronie´s disease with Tamoxifen. Br J Urol 1992; 70: 648-651.
24. Ralph DJ, Mirakian R, Pryor JP et al. The immunological features of Peyronie´s diasease. J Urol 1996; 155: 159-162.
25. Skolarikos A, Alargof E, Rigas A et al. Schockwave therapy as first line treatment for Peyronie´s disease. J Endourol 2005; 19: 11-14.
26. Stewart S et al. Increased levels of anti-elastin bodies in patients with Peyronieœ disease. J Urol 1994; 152: 105-106.
27. Usta MF, Bivalacqua TJ, Sanabria J et al. Patient and Partner satisfaction and long-term results after surgical treatment for Peyronie´s disease. Urology 2003; 62: 105-109.
28. Weidner W, Hauck EW, Schnitker J. Patassium paraaminobenzoate (POTABA) in the treatment of Pyeronie´s disease. Eur Urol 2005; 47: 530-535.
Labels
Paediatric urologist UrologyArticle was published in
Urological Journal
![Issue 1](https://www.prolekare.cz/media/cache/resolve/journal_issue/media/image_pdf/7ee302c6f9329e46ff21238adbb1b440.jpeg)
2006 Issue 1
Most read in this issue
- INTRACAVERNOUS VASOACTIVE THERAPY OF ERECTILE DYSFUNCTION
- PENILE PLASTIC INDURATION (PEYRONIE'S DISEASE)
- TRANSSEXUALISM AND SEX CONVERSION SURGERY
- MALE FACTOR INFERTILITY: EVALUATION AND MANAGEMENT